GLP-1 Muscle Loss — The Hidden Risk Titelbild

GLP-1 Muscle Loss — The Hidden Risk

GLP-1 Muscle Loss — The Hidden Risk

Von: Inception Point Ai
Jetzt kostenlos hören, ohne Abo

Über diesen Titel

 GLP-1 drugs like Ozempic trigger dramatic weight loss, but up to 40% may be muscle, not fat. Dr. Ben Synth unpacks the hidden metabolic cost, science-backed preservation strategies, and breakthrough therapies that could revolutionize how we lose weight without losing strength.

For more content like this, visit QuietPlease.aiCopyright 2025 Inception Point Ai
Folgen
  • GLP-1 Muscle Loss — Uncover the hidden risk with Dr. Ben Synth

    GLP-1 Muscle Loss — Uncover the hidden risk with Dr. Ben Synth
    Apr 7 2026
    Join Dr. Ben Synth as he uncovers the hidden cost of GLP-1 drugs like Ozempic and Mounjaro—your muscle mass. Discover the science behind muscle loss, explore next-generation therapies to prevent it, and learn practical strategies to protect lean tissue while shedding pounds.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    1 Min.
  • GLP-1 Muscle Loss — The Hidden Risk - Your Survival Guide for Protecting Muscle on Ozempic

    GLP-1 Muscle Loss — The Hidden Risk - Your Survival Guide for Protecting Muscle on Ozempic
    Apr 7 2026
    Host Ben Synth examines research showing two-thirds of GLP-1 weight loss can be muscle, not fat. This episode covers evidence-based strategies to preserve muscle during Ozempic, Wegovy, or Mounjaro treatment: resistance training protocols, protein timing, hydration, and multidisciplinary care. Learn why exercise prevents weight regain after stopping medication.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    25 Min.
  • GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug

    GLP-1 Muscle Loss — The Hidden Risk - The Race to Build a Better Drug
    Apr 7 2026
    Host Ben Synth explores groundbreaking research on GLP-1 weight loss drugs and muscle preservation. He examines the BELIEVE study combining semaglutide with bimagrumab, which achieved 92.8% fat loss versus lean tissue loss, and discusses revolutionary continuous biosensor technology tracking muscle breakdown in real-time for patients on medications like Ozempic and Mounjaro.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Mehr anzeigen Weniger anzeigen
    25 Min.
Noch keine Rezensionen vorhanden